8IS2.F - Invictus MD Strategies Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.2516
+0.0131 (+5.49%)
At close: 11:17AM CEST
Stock chart is not supported by your current browser
Previous Close0.2385
Open0.2516
Bid0.2476 x 0
Ask0.2605 x 0
Day's Range0.2516 - 0.2516
52 Week Range0.2385 - 1.5000
Volume10
Avg. Volume731
Market Cap34.078M
Beta (3Y Monthly)12.15
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire11 days ago

    Invictus announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia, July 09, 2019 -- Vancouver, BC, July 9, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire17 days ago

    Invictus announces Non-Brokered Private Placement

    Vancouver, British Columbia, July 03, 2019 -- Vancouver, BC, July 3, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire18 days ago

    INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

    FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Ventures Inc. (“AB Ventures”), a company which Invictus is a 25% shareholder, is a late stage applicant to obtain a cultivation license under the Cannabis Act. AB Ventures received the approval to proceed to construction and will submit its evidence package upon completion of such construction.

  • GlobeNewswire22 days ago

    INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

    FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. “We are pleased with the progress on reducing the cost of Invictus’ operations and the increases to date on the income generation capacity of the Company. Continued focus on increasing capacity and cost reduction is paramount in developing a profitable business,” stated Mr. Trevor Dixon, Chief Executive Officer of Invictus.

  • GlobeNewswire24 days ago

    INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

    Vancouver, June 26, 2019 -- Vancouver, BC, June 26, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,.

  • GlobeNewswirelast month

    Invictus announces Annual General Meeting Date

    Vancouver, British Columbia, June 20, 2019 -- Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswirelast month

    UPDATE ON ACREAGE PHARMS LTD.

    Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.

  • GlobeNewswirelast month

    INVICTUS ANNOUNCES APPOINTMENT TO BOARD

    FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director.  Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.

  • GlobeNewswirelast month

    INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT

    Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.

  • GlobeNewswire2 months ago

    INVICTUS ANNOUNCES CHANGES TO BOARD

    FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director.  Mr. Aaron Bowden has submitted his resignation as a Director in order to devote more time to his other business interests.  Mr. Bowden will continue to serve the Company as an advisor.  Mr. Bowden was appointed to the Board of Directors on August 19, 2016 and served as Chair of the Audit Committee.

  • GlobeNewswire2 months ago

    INVICTUS ANNOUNCES CHANGE TO MANAGEMENT AND BOARD

    FRA: 8IS2) announces that the Board of Directors (the “Board”) has accepted Mr. George E. Kveton’s resignation as Chief Executive Officer (“CEO”) of the Company and Mr. Trevor Dixon, a member of the Board, will be assuming the role of CEO. “I am proud to be serving as the Company’s CEO,” said Mr. Dixon.  “I am committed to the long term and ongoing success of the Company as we work to improve production, increase revenue and decrease the cost of operations.

  • GlobeNewswire2 months ago

    Invictus Withdraws Plans for NASDAQ Listing and Related Share Consolidation

    FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock Market LLC (“NASDAQ”), as well as plans for the share consolidation that would have been required to meet NASDAQ’s minimum share price listing threshold. Plans for the NASDAQ listing and a share consolidation were originally announced in press releases dated January 17, 2019 and January 21, 2019.

  • GlobeNewswire3 months ago

    INVICTUS GRANTS OPTIONS

    Vancouver, BC, April 26, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive.

  • GlobeNewswire3 months ago

    Invictus To Develop CBD-Infused Sodas with Rock Icon Gene Simmons and Simmons’ Moneybag™ Sodas

    FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas (“MoneyBag™”) and  Rock Steady Sodas, Inc. (“Rock”) (each a “Party” and collectively the “Parties”) to develop a line of non-alcoholic, CBD-infused beverages for distribution in the United States and Canada. Rock will contribute expertise with existing premium soda recipes to be used with CBD and generations of bottling and distribution experience.

  • GlobeNewswire4 months ago

    INVICTUS MAKES FIRST SHIPMENT TO ONTARIO CANNABIS STORE

    Vancouver, BC, April 01, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment.